receptors, purinergic p1

Preferred Label : receptors, purinergic p1;

MeSH definition : A class of cell surface receptors that prefer ADENOSINE to other endogenous PURINES. Purinergic P1 receptors are widespread in the body including the cardiovascular, respiratory, immune, and nervous systems. There are at least two pharmacologically distinguishable types (A1 and A2, or Ri and Ra).;

MeSH synonym : adenosine receptors; purinergic p1 receptors; purinoceptor, p1; p1 receptor, purinergic; receptor, purinergic p1; receptors, adenosine; adenosine receptor; receptor, adenosine; purinergic p1 receptor; p1 purinoceptor; p1 purinoceptors; purinoceptors, p1; p1 receptors, purinergic;

MeSH annotation : general or unspecified; prefer specifics;

Wikipedia link : https://en.wikipedia.org/wiki/Adenosine receptor;

Is substance : O;

Details

Origin ID

D018047;

UMLS CUI

C0001471;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- analysis [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- drug effects [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- physiology [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- ultrastructure [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Adenosine Receptor [NCIt concept]
Currated CISMeF NLP mapping
- Purinergic P1 Receptor [NCIt concept]
Indexing information
- (2-amino-4,5,6,7-tetrahydrobenzo(b)thiophen-3-yl)(4-chloronaphthalen-1-yl)methanone [MeSH Supplementary Concept]
- (2-amino-4,5,6,7-tetrahydrobenzo(b)thiophen-3-yl)(4-iodonaphthalen-1-yl)methanone [MeSH Supplementary Concept]
- 1-((7-methyl-2-phenylimidazo(1,2-a)(1,3,5)triazin-4-yl)amino)acetone [MeSH Supplementary Concept]
- 1-benzyl-3-propyl-1H,3H-pyrido(2,1-f)purine-2,4-dione [MeSH Supplementary Concept]
- 2,4-diethyl-1-methyl-3-(ethylsulfanylcarbonyl)-5-ethyloxycarbonyl-6-phenylpyridinium [MeSH Supplementary Concept]
- 2-((1-phenylpropyl)amino)adenosine [MeSH Supplementary Concept]
- 2-((phenylisopropyl)amino)adenosine [MeSH Supplementary Concept]
- 2-(2-phenylethoxy)adenosine [MeSH Supplementary Concept]
- 2-(3-hydroxy-3-phenyl-1-propyn-1-yl)-5'-N-ethylcarboxamidoadenosine [MeSH Supplementary Concept]
- 2-hexyloxyadenosine [MeSH Supplementary Concept]
- 3,6-dichloro-2'-isopropyloxy-4'-methylflavone [MeSH Supplementary Concept]
- 4-amino-1-(2-chloro-2-phenylethyl)-1H-pyrazolo(3,4-b)pyridine-5-carboxylic acid ethyl ester [MeSH Supplementary Concept]
- 4-amino-6-benzylamino-1,2-dihydro-2-phenyl-1,2,4-triazolo(4,3-a)-quinoxalin-1-one [MeSH Supplementary Concept]
- 5'-O-ethyl-N-(3-iodobenzyl)adenosine [MeSH Supplementary Concept]
- 5-(((4-fluorosulfonylphenyl)amino)carbonyl)amino-8-n-propyl-2-(2-furyl)pyrazolol(4,3-e)1,2,4-triazolo(1,5-c)pyrimidine [MeSH Supplementary Concept]
- 5-(((4-pyridyl)amino)carbonyl)amino-8-methyl-2-(2-furyl)pyrazolo(4,3-e)1,2,4-triazolo(1,5-c)pyrimdiine [MeSH Supplementary Concept]
- 8-butylamino-N(6)-cyclopentyladenosine [MeSH Supplementary Concept]
- 8-butylaminoadenosine [MeSH Supplementary Concept]
- 8-cyclohexylcaffeine [MeSH Supplementary Concept]
- 8-cyclopentyl-3-(3-(4-fluorosulfonylbenzamido)propyl)-1-propylxanthine [MeSH Supplementary Concept]
- 8-dipropyl-8-cyclopentylxanthine [MeSH Supplementary Concept]
- CVT 2759 [MeSH Supplementary Concept]
- FSPTP pyrimidine [MeSH Supplementary Concept]
- KF 17387 [MeSH Supplementary Concept]
- KF 20274 [MeSH Supplementary Concept]
- KFM 19 [MeSH Supplementary Concept]
- KMCP 98 [MeSH Supplementary Concept]
- MRS 1097 [MeSH Supplementary Concept]
- MRS 1204 [MeSH Supplementary Concept]
- MRS 1595 [MeSH Supplementary Concept]
- MRS 1740 [MeSH Supplementary Concept]
- MRS 1741 [MeSH Supplementary Concept]
- N(6)-(4-sulfophenyl)adenosine [MeSH Supplementary Concept]
- N(6)-benzyl-5'-N-ethylcarboxamidoadenosine [MeSH Supplementary Concept]
- N(6)-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine [MeSH Supplementary Concept]
- N-(3-(2-pyridinyl)isoquinolin-1-yl)benzamidine [MeSH Supplementary Concept]
- N-(3-iodobenzyl)-5'-O-methyladenosine [MeSH Supplementary Concept]
- N6-(4-(((4-((((2-((((isothiocyanatophenyl)amino)thiocarbonyl)amino)ethyl)amino)carbonyl)methyl)anilino)carbonyl)methyl)phenyl)adenosine [MeSH Supplementary Concept]
- RS 74513-000 [MeSH Supplementary Concept]
- VUF 5455 [MeSH Supplementary Concept]
- VUF 5472 [MeSH Supplementary Concept]
- VUF 8504 [MeSH Supplementary Concept]
- WRC 0571 [MeSH Supplementary Concept]
- XH-14 [MeSH Supplementary Concept]
- alpha-((4-(methylamino)-1-phenylpyrazolo(3,4-d)pyrimidin-6-yl)thio)hexanamide [MeSH Supplementary Concept]
- alpha-((4-amino-1-phenylpyrazolo(3,4-d)pyrimidin-6-yl)thio)hexanamide [MeSH Supplementary Concept]
- propyl 1-ethyl-8-oxo-3-phenyl-5,6,7,8-tetrahydro-7-thiaisoquinoline-4-carboxylate [MeSH Supplementary Concept]
- tecadenoson [MeSH Supplementary Concept]
Record concept(s)
- receptors, purinergic P1 [MeSH concept]
Related MeSH Supplementary Concept(s)
- purinoceptor RDC7 [MeSH Supplementary Concept]
- purinoceptor RDC8 [MeSH Supplementary Concept]
Related MeSH term(s)
- purinergic P1 receptor agonists [MeSH Descriptor]
- purinergic P1 receptor antagonists [MeSH Descriptor]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Receptor [UMLS semantic type]
UMLS correspondences (same concept)
- Purinergic P1 Receptor [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients